date:Dec 04, 2012
to Olam.
Olam expects growth to come from sales through its existing customer network, in addition to sales growth from Dehydros customers in the Middle East and Europe. Overall, the investment is expected to deliver 28% in EBITDA margin and 45% in Equity IRR at steady-state.